Health & Wellness

New York – September 11, 2026 -- Suunto has launched the Run 2, a running watch weighing 35 grams that starts at $349, with pre-orders opening today and global availability the same day.

The watch adds a brighter screen and longer battery life than its predecessor

The Run 2 features a 1.32-inch AMOLED display reaching 2,000 nits, three times brighter than the original Suunto Run, designed to stay readable in direct sunlight. Battery capacity increases by 29 percent over the prior model, giving roughly 10 days of everyday use or up to 24 hours with dual-band GNSS tracking active. At 11.7mm thick, the watch body includes a stainless steel bezel, Gorilla Glass and 5 ATM water resistance.

Hamburg – September 11, 2026 -- Philips has unveiled the Lumea IPL 9900 Pro, a new at-home hair removal device priced at €799.99, now available on philips.de and through retailers.

Live audio feedback guides users through treatments

The device pairs with the Lumea IPL app, which tracks movement in real time during leg and arm treatments. It delivers live audio cues to help users maintain correct technique, while step-by-step visual guidance for legs ensures no area is missed.

Results can last up to five years with monthly upkeep

Philips reports hair reduction of more than 80% on legs after just two treatments. After an initial treatment phase, users need only one monthly touch-up session to maintain smooth skin for up to five years, according to the company.

San Antonio – – September 11, 2026 -- Complex breast implant revision surgery is not a simple swap of one implant for another, according to Dr. Gary Lawton, a Yale-trained, American Board of Plastic Surgery-certified surgeon practicing in San Antonio. Dr. Lawton, who has performed tens of thousands of breast implant operations over more than 25 years, says durable correction depends on the surgeon first reconstructing the history and mechanics of the original operation before making an incision.

Tempe, Arizona – September 11, 2026 -- Nootropics Depot has launched SulfoMax, a powdered sulforaphane supplement designed to fix a chemistry problem the company says undermines standard capsule versions of the compound.

Sulforaphane, a compound studied for its role in cellular defense and cognitive resilience, is too unstable to bottle directly. Most supplements instead combine glucoraphanin, a stable precursor, with the enzyme myrosinase inside a capsule, relying on the two to react after swallowing.

Lab testing found stomach acid disables the key enzyme

Nootropics Depot's analytical lab ran that reaction through a Distek dissolution tester using simulated gastric fluid. At stomach-acid pH, myrosinase was largely inactivated, meaning much of the precursor in a conventional capsule can pass through the body without converting into active sulforaphane.

New York – September 11, 2026 -- COSRX has launched a nine-product 5 Peptide Lip Collection exclusively with Ulta Beauty in the U.S., available online at Ulta.com starting September 6, 2026.

Three products anchor the lineup with prices from $15 to $16

The collection includes the 5 Peptide Collagen Lip Fill Tinted Treatment at $16, available in seven shades, alongside the 5 Peptide B5 Barrier Repair Salve Lip Balm and the 5 Peptide Ceramide Barrier Comfort Lip Mask, each priced at $15.

A 5 Peptide Complex anchors every formula in the range

COSRX built the collection around a 5 Peptide Complex combined with Collagen, Panthenol and Ceramides. The brand says the formulas target dryness, rough texture and the appearance of lip lines while maintaining smooth, comfortable wear.

Kingman, Ariz. – September 11, 2026 -- A new web app called Amino Minder launched this week, offering peptide, GLP-1, TRT, and HRT users a tool that graphs estimated plasma levels over time instead of just logging when a dose was taken.

The app models how compounds rise and decay in the body

Built by Baya Lobo LLC, Amino Minder uses a one-compartment pharmacokinetic model to estimate and chart a rise-and-decay curve for each tracked compound. Users can adjust the model for route of administration, individual half-life, and a configurable clearance modifier.

Rochester – September 11, 2026 -- Families facing a sudden nursing home admission often assume every option to protect savings and property has vanished, but attorney Andrew R. Randisi of Weinstein & Randisi says that isn't always true.

Many families wait until a health crisis forces the issue

According to a HelloNation feature on Randisi's insights, most families delay Medicaid planning until a parent suddenly needs nursing home care or a loved one's health declines sharply. That timing creates immediate pressure around retirement savings, property, and long-term financial stability.

Two common assumptions about timing are usually wrong

Some families believe asset protection becomes impossible once long-term care starts. Others assume a single strategy can shield all savings and property no matter when planning begins. The article states neither assumption holds up under current Medicaid rules.

Summit, N.J. – – September 11, 2026 -- A new over-the-counter pain reliever combining acetaminophen and naproxen sodium in a single pill has cleared two Phase 3 clinical trials, with data presented this week at the 20th Annual PAINWeek Conference in Las Vegas, running September 8-11, 2026.

TYLENOL with Naproxen pairs 650 mg of acetaminophen with 220 mg of naproxen sodium, a combination the FDA approved in July 2026 as the first and only OTC product of its kind. The formula starts working in under 30 minutes and delivers relief for up to 12 hours, according to Kenvue, the brand's parent company.

Irving, Texas – September 11, 2026 -- Caris Life Sciences has launched a national awareness campaign called "Math," featuring actor Kevin Costner, to promote Caris Detect, a multi-cancer early detection blood test now available across the United States.

The blood test screens for cancer signals before symptoms appear

Caris Detect combines ultra-deep Whole Genome Sequencing, Whole Transcriptome Sequencing, and artificial intelligence to scan the bloodstream for molecular signals associated with cancer. Unlike tests that check only a limited set of biomarkers, the company says its approach analyzes the entire genome and transcriptome for a broader molecular picture. The test is designed to complement, not replace, routine cancer screenings.

Denver – September 11, 2026 -- Spring Fertility has opened a new clinic in Denver, Colorado, expanding its network as the company marks 10 years in business and more than 10,000 patient pregnancies. The clinic, located at 1900 Lawrence Street, began accepting appointments on September 8.

Two Denver-area physicians lead the new clinic

Dr. Debra Minjarez, who spent more than 15 years as Medical Director of the Colorado Center for Reproductive Medicine (CCRM), will serve as Medical Director of Spring Fertility Denver. She is joined by Dr. Natalia Grob, who previously practiced at Kindbody Denver and Conceptions Reproductive Associates of Colorado.

"Every patient has a unique story, and we're committed to delivering individualized treatment plans backed by cutting-edge science while ensuring every patient feels seen, heard, and supported throughout their journey," Minjarez said.